Replies to post #585891 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

HyGro,

Thank you for mentioning the NIH! You need better sources of information and the NIH is a great starting point!

I recommend starting over and doing research about the DCVax-L story beginning years ago and leading up to the 2022 JAMA Oncology peer review and the 2023 MIA license approval.

The first and best point of research about this cell-based product is Dr. Liau. Dr. Liau and the NIH deserve the most credit for the development of the DCVax-L platform technology.

https://doi.org/10.3171/2020.12.FOCUS20954








https://www.uclahealth.org/news/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020

https://www.uclahealth.org/news/brain-cancer-discovery-clinical-trials

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171539116

[alphapuppy]

Hygo. Do you know how much Keytruda cost? It’s a pretty significant investment. Let me tell you it’s expensive.